Trabectedin Injection is a specialised oncology medicine used in the treatment of certain advanced cancers. For international pharmaceutical buyers, distributors, hospitals and authorised healthcare procurement organisations, understanding the product, therapeutic applications, documentation and supply considerations is important when evaluating Trabectedin for pharmaceutical sourcing.
What Is Trabectedin Injection?
Trabectedin is an antineoplastic medicine that works through interactions with DNA and cellular processes involved in tumour growth. It is used under specialist medical supervision and is administered by intravenous infusion.
Trabectedin has established clinical uses in selected patients with advanced soft-tissue sarcoma and, in combination with pegylated liposomal doxorubicin, certain cases of relapsed platinum-sensitive ovarian cancer. Treatment decisions should always follow the applicable approved product information and be made by qualified healthcare professionals.
Trabectedin Injection: Key Product Information
For pharmaceutical procurement teams, important product information may include:
Active ingredient: Trabectedin
Therapeutic category: Antineoplastic / oncology medicine
Dosage form: Powder for preparation of an intravenous infusion, depending on the specific product
Route of administration: Intravenous infusion
Clinical area: Oncology
Primary applications: Selected advanced soft-tissue sarcoma and relapsed platinum-sensitive ovarian cancer, according to applicable authorised indications
The exact strength, presentation, packaging and product specifications should be confirmed with the supplying pharmaceutical company before procurement.
Trabectedin Injection for International Pharmaceutical Buyers
International buyers sourcing Trabectedin Injection should assess the supplier's pharmaceutical credentials, product specifications, batch documentation, packaging information and applicable quality documents before placing an order.
For UK pharmaceutical buyers, additional attention should be given to applicable UK medicine importation, wholesale distribution and regulatory requirements. The buyer and supplier should establish the appropriate supply route and documentation before shipment.
How to Source Trabectedin Injection from India
India is a major pharmaceutical supply and export market, making Indian pharmaceutical exporters a potential source for international B2B medicine procurement.
When evaluating a Trabectedin Injection supplier from India, buyers should consider:
Company and export credentials
Product availability and specifications
Quality and batch documentation
Packaging and shipping requirements
Destination-country regulatory requirements
Commercial terms and order requirements
International logistics and documentation
Trabectedin Injection Supplier and Exporter
Cordium Pharmaceuticals Pvt Ltd is an India-based pharmaceutical exporter serving international B2B medicine buyers. Buyers interested in Trabectedin Injection supply from India can contact Cordium Pharmaceuticals to discuss product availability, specifications, documentation, quotation and international export requirements.
Frequently Asked Questions
What is Trabectedin Injection used for?
Trabectedin is used for selected advanced soft-tissue sarcoma cases and certain relapsed platinum-sensitive ovarian cancer cases, according to applicable approved indications.
How is Trabectedin administered?
Trabectedin is administered by intravenous infusion under appropriate specialist medical supervision.
Can international buyers source Trabectedin Injection from India?
International pharmaceutical buyers may source medicines from India subject to the product's regulatory status and the import, licensing and pharmaceutical requirements of the destination country.
Disclaimer: This article is for general pharmaceutical and procurement information only. Trabectedin is a prescription oncology medicine. Its use, supply, importation and administration must comply with applicable laws, regulations and approved product information.
